ArticleGlia2026
Progenitor Timing Shapes NG2-Glia Fate and Oligodendrocyte Differentiation.
Article in Glia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The developmental identity and fate of NG2-glia remain debated: are they transient oligodendrocyte precursors or a distinct, self-renewing glial population? Here, we examined how the temporal origin of progenitors influences NG2-glia and oligodendrocyte lineages in the dorsal cortex. Using in utero and postnatal StarTrack electroporation at E12, E14, E16, and P0, we lineage-traced their progeny to P30 and P90, performing a clonal analysis in adult mouse brains. Progenitors labeled at E16 generated significantly larger and more widely dispersed NG2-glia clones, whose contribution increased from P30 to P90, suggesting enhanced proliferative capacity. In contrast, P0-derived progenitors showed reduced NG2-glia maintenance and a strong bias toward oligodendrocyte differentiation, forming larger OL clones. Clonal heterogeneity, including mixed NG2-glia/OL clones, was observed across all stages but peaked at E16. These results identify E16 as a critical window for NG2-glia expansion and self-renewal, while P0 marks a transition toward oligodendrocyte lineage restriction, establishing a developmental framework for adult NG2-glia heterogeneity and maybe a regenerative potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.